4 Year Trial of HIV Vaccine

| No Comments

Just announced from the Fred Hutchinson Cancer Research Center in Seattle; The launch of the first large-scale study to evaluate a candidate HIV vaccine on the African continent was announced today by study collaborators in the United States and South Africa. The trial will involve up to 3,000 participants at five sites throughout South Africa and is expected to continue for four years.

Leave a comment

About this Entry

This page contains a single entry by published on February 12, 2007 11:01 AM.

Lung cancer rates higher among female non-smokers was the previous entry in this blog.

Neurocysticercosis plagues states along Mexico border is the next entry in this blog.

Find recent content on the main index or look in the archives to find all content.